The Treatment of Myelin Oligodendrocyte Glycoprotein Antibody Disease: A State-of-the-Art Review.

Bart Kevin ChwaliszMichael Levy

Published in: Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society (2022)

While acute MOGAD attacks are usually treated with high-dose IV corticosteroids, longer oral corticosteroid tapers may prevent rapid relapse. Multiple long-term treatment strategies are being employed in recurrent MOGAD, with IVIg is emerging as probably the most effective therapy.

Keyphrases

high dose
liver failure
low dose
respiratory failure
drug induced
aortic dissection
replacement therapy
cell therapy